Sensorimotor Tests – Auditory Event-related potentials (AERP)
Auditory event-related potentials (AERP) are neurophysiological correlates of sound perception and cognitive processes
Key Research Model Applications of Auditory Event-related Potentials (AERP)
Event related potentials (ERPs) are subtle changes in electrical activity generated in response to specific motor, sensory, or cognitive events. In clinical research, ERPs are often studied using an auditory oddball paradigm, where participants listen to a series of regular tones with occasional different or “odd” tones.
Clinical EEG recording in FXS patients has shown differences in event -related potential amplitudes. Such phenomenon is also observed in the Fmr1 KO mice, making this experiment a highly valued translational test for model characterization and intervention studies.
During an ERP recording session, multiple trials are provided with a 100 msec white noise stimulus (~70 dB), with 4-6 sec inter trial interval. Trials with movement artifacts (deducted from XYZ activity) are excluded, to generate a clean average AERP trace for the auditory cortex electrode.
Les tests comportementaux chez la souris en toute simplicité.
Découvrez notre vaste gamme de tests comportementaux et cognitifs validés et sur mesure destinés aux rongeurs, conçus pour faire progresser vos recherches.
AERP Sample Data
Experimental setup for auditory event-related potential (AERP) EEG recording.
This experiment is conducted in a sound attenuating chamber (1). Mouse is implanted with a wireless EEG recording system that also collects body movement (XYZ activity) (2) and placed in a Plexiglas cylinder (3). A speaker is set up with adjustable volume and frequency to generate specific acoustic stimuli (4). A recorder is placed inside the chamber to record the sound (5), together with the infrared light synchronisation pulse generator (6) to help synchronize the acoustic stimuli with the recorded EEG signals. The figure shows a concept trace, based on internal data and literature.
Les personnes qui travaillent sur vos recherches
Thomas Vogels, docteur en sciences, In Vivo Neurologie Directeur d'étude
Dirige une équipe d'experts scientifiques possédant une vaste expérience de nos modèles de neurologie afin de vous aider à choisir le modèle le plus adapté et vous guide dans votre conception optimale conception d’étude. Nous vous proposons la solution pour accélérerele rythme le développement de vos médicaments.
Restez curieux : d'autres articles à découvrir
Neurodevelopmental disorder mouse models at InnoSer — TSC, Rett & STXBP1
in this month's update, we invite you to explore recent developments in rare neurodevelopmental disorders associated with epilepsy and seizure phenotypes. We highlight emerging therapeutic approaches, discuss the importance of selecting translationally relevant...
Plasma NfL, p-tau217, or Aβ42/40: Which Alzheimer’s disease biomarkers should you include in your preclinical efficacy study?
A practical guide to preclinical Alzheimer’s disease biomarkers panel selection when you’re considering outsourcing to a specialist neurology CRO Biomarkers have transformed Alzheimer's disease clinical trials, enabling diagnosis confirmation for trial eligibility,...
Transgenic Amyloid, Tau, Seeding, or combined Amyloid/Tau pathology mouse models — which is the right one for your drug development program?
A practical guide to model selection when outsourcing your Alzheimer's disease efficacy study to a specialist neurology CRO Choosing the right Alzheimer's disease mouse model is one of the most consequential early decisions in a preclinical drug development program....
Morris Water Maze, Rotarod and beyond: How do you build a comprehensive behavioral test battery when outsourcing your preclinical Alzheimer’s disease efficacy study?
A practical introduction to behavioural test battery selection when outsourcing your Alzheimer's disease efficacy study to a specialist neurology CRO When outsourcing a preclinical Alzheimer's disease efficacy study, behavioral endpoint selection is one of the most...
Accréditation AAALAC
InnoSer a obtenu l'accréditation AAALAC, ce qui témoigne de notre engagement en faveur d'une prise en charge et d'une utilisation responsables des animaux. AAALAC International est une organisation à but non lucratif qui promeut le traitement sans cruauté des animaux dans le domaine scientifique par le biais de programmes volontaires d'accréditation et d'évaluation. Les sites d'InnoSer aux Pays-Bas et en Belgique sont accrédités par l'AAALAC depuis 2016 et 2020, respectivement. Pour en savoir plus sur le programme d'accréditation de l'AAALAC, cliquez ici.
Bien-être animal
Les « 3R » ont une incidence sur tous les domaines, depuis les changements politiques et réglementaires jusqu’au développement et à l’adoption de nouvelles technologies et approches. C’est pourquoi InnoSer s’engage en permanence à suivre ces processus. Les mesures que nous mettons en œuvre optimisent notre capacité à remplacer, réduire et perfectionner l’utilisation des animaux et facilitent notre engagement envers ces principes dans le cadre de la recherche et du développement de médicaments.
info@innoserlaboratories.com
Liens rapides